5mg and 10mg tablets 

Combination products with tamsulosin are not approved; prescribe components separately.

1mg & 2mg tablets

• MR Tablets - 7.5mg, 15mg

• Capsules: 20mg, 40mg
• Moderate to severe stress incontinence in combination with supervised pelvic floor excercises only

•  MR Tablets - 4mg, 8mg

• 2.5mg and 5mg tablets

• 2.5mg in 5ml & 1mg/1ml oral solution

• Immediate release oxybutinin is not appropriate for frail elderly people or those with cognitive impairment.

• Tablets: 15mg

• Tablets: 20mg

• Approved for use when antimuscarinics don’t work, are not suitable or side effects are unacceptable, in line with NICE guidance. 

• Oxybutinin patch 36mg (releases approximately 3.9mg in 24 hours). 
• Approved for patients in whom two antimuscarinics have proved to be efficacious but the side effects are intolerable, or for patients who cannot swallow tablets.

• 75mg film-coated tablets
  • Approved for treating symptoms of overactive bladder syndrome in adults in line with NICE

• Methylphenidate is approved for use as a third line option (after e.g. antimuscarinics, imipramine, and pelvic floor exercises) in the treatment of giggle incontinence in children. Its use should be subject to a therapeutic trial to be reviewed after two months and considered for Shared Care if patients have been shown to respond after the trial period.

Prescribe by brand name

• 5mg & 10mg tablets
• 5mg, 10mg, 20mg, 30mg and 40mg m/r capsules (Medikinet® XL)
• 10mg, 20mg & 30mg m/r capsules (Equasym® XL)
• 18mg, 27mg, 36mg & 54mg m/r tablets (first choice: Atenza® XL; second choice: Xaggitin® XL)
  
  • Existing patients who are prescribed Concerta® XL should be reviewed and switched to an appropriate bioequivalent option
  • Atenza XL and Xaggitin XL are bioequivalent to Concerta XL
• 2mg/ml oral solution sugar free (Consilient Health Ltd). Only for those patients unable to take solid dosage forms across the whole dosage range. This preparation contains the following excipients with known effect: Propylene glycol 90mg/ml, Sorbitol 175mg/ml, Sodium benzoate 1mg/ml NPPG Position statement ‘Choosing an Oral Liquid Medicine for Children’ advises on maximum content of propylene glycol and benzoates dependent on age.

• The effects of Equasym® XL last for about 8 hours compared with about 12 hours for Xaggitin® XL. 

See also formulary entry in chapter 4 for management of ADHD and narcolepsy.

• Vaginal Devices for female stress urinary incontinence (e.g. Diveen, Contiform, Efemia)
• Approved for use in line with NTAG / NICE
• Product should only be initiated by a specialist pelvic health physiotherapists and specialist nurses